Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Qilu Pharmaceutical Co., Ltd.)"
Count: 104
Selected: 0
NCT IDTitle
NCT06261359A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
NCT06254235Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
NCT06232902A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers
NCT06173011A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
NCT06151587A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
NCT06058000A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06047431A Study of QL1706H in Patients With Advanced Solid Tumors
NCT06041035A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
NCT06019013A Study of QLF3108 in Participants With Advanced Solid Tumor
NCT05976568A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
NCT05973149Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
NCT05950516Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
NCT05932888Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects
NCT05920876A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
NCT05884801Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors
NCT05860530Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers
NCT05851027Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia
NCT05830045A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors
NCT05829616A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors
NCT05823285A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
NCT05823246Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
NCT05803642A Study of Olanzapine in Patients With Acute Agitation
NCT05802342A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer
NCT05801107Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
NCT05801094A Phase I Study of QL1604 for Advanced Solid Tumors
NCT05799820QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC
NCT05758519A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19
NCT05716126Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers
NCT05703204A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT05690945A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
NCT05689203A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
NCT05649761A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors
NCT05629949A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer
NCT05621330Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia
NCT05603039A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma
NCT05576272A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
NCT05557565A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer
NCT05555212To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
NCT05554913Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia
NCT05531994Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers
NCT05528198Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers
NCT05488821Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.
NCT05487391A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
NCT05461287Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors
NCT05458076A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants
NCT05446883QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
NCT05345236A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)
NCT05329025A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer
NCT05309629Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer
NCT05278832A Study of QLS31905 in Patients With Advanced Solid Tumors